You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 102 No. 11, November 1984 TABLE OF CONTENTS
  Archives
  •  Online Features
  CLINICAL SCIENCES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (36)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Flurbiprofen Pretreatment in Argon Laser Trabeculoplasty for Primary Open-Angle Glaucoma

Robert N. Weinreb, MD; Alan L. Robin, MD; George Baerveldt, MD; Michael V. Drake, MD; Michael Blumenthal, MD; Jacob Wilensky, MD

Arch Ophthalmol. 1984;102(11):1629-1632.


Abstract

• We examined the influence of topically administered flurbiprofen sodium 0.03%, a potent prostaglandin inhibitor, on the inflammatory response and intraocular pressure following argon laser trabeculoplasty. Our investigation included one eye of each of 118 patients with primary open-angle glaucoma in whom laser trabeculoplasty was indicated. Sixty-three patients received flurbiprofen and 55 received a vehicle during the two-hour period immediately preceding laser therapy and for one week postoperatively. No significant differences in postoperative IOPs were noted between groups. However, when we considered conjunctival erythema at 24 hours or control of inflammation at the termination of the investigation, the eyes receiving flurbiprofen had less inflammation than did the vehicle-treated eyes.



Author Affiliations

From the Departments of Ophthalmology, the University of California, San Diego (Dr Weinreb); The Johns Hopkins University, Baltimore (Dr Robin); the University of Southern California, Los Angeles (Dr Baerveldt); the University of California, San Francisco (Dr Drake); the Chaim Sheba Medical Center, Tel Hashomer, Israel (Dr Blumenthal); and the University of Illinois, Chicago (Dr Wilensky).


Footnotes

Accepted for publication Sept 9, 1984.

Reprint requests to the Department of Ophthalmology, UCSD Medical Center, 225 Dickinson St (H-898), San Diego, CA 92103 (Dr Weinreb).

This study was supported in part by Allergan Pharmaceuticals, Inc, Irvine, Calif, which also supplied the flurbiprofen sodium. Ron DeGryfe, MS, MA, assisted with the statistical analysis.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Membrane formation in the chamber angle after failure of argon laser trabeculoplasty
HOLLÓ
Br J Ophthalmol 2000;84:673b-673.
FULL TEXT  

Anti-inflammatory Effect of Diclofenac Drops After Argon Laser Trabeculoplasty
Herbort et al.
Arch Ophthalmol 1993;111:481-483.
ABSTRACT  

Inflammation Patterns After Laser Trabeculoplasty Measured With the Laser Flare Meter
Mermoud et al.
Arch Ophthalmol 1992;110:368-370.
ABSTRACT  

Prevention of the Rise in Intraocular Pressure Following Neodymium-YAG Posterior Capsulotomy Using Topical 1% Apraclonidine
Pollack et al.
Arch Ophthalmol 1988;106:754-757.
ABSTRACT  

Effects of ALO 2145 on Intraocular Pressure Following Argon Laser Trabeculoplasty
Robin et al.
Arch Ophthalmol 1987;105:646-650.
ABSTRACT  

Intraocular Pressure Elevation After Pupillary Dilation in Open Angle Glaucoma
Shaw and Lewis
Arch Ophthalmol 1986;104:1185-1188.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1984 American Medical Association. All Rights Reserved.